Related Experiment Video

Updated: Jun 19, 2026

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
10:26

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions

Published on: December 20, 2017

Short peptides derived from the BAG-1 C-terminus inhibit the interaction between BAG-1 and HSC70 and decrease breast

Adam Sharp1, Ramsey I Cutress, Peter W M Johnson

  • 1Cancer Research UK Centre, Cancer Sciences Division, University of Southampton, School of Medicine, Southampton General Hospital, Southampton S016 6YD, UK.

FEBS Letters
|October 6, 2009
PubMed

Insights

Researchers identified a small BAG-1 protein domain crucial for binding HSC70. Peptides from this domain inhibited cancer cell growth, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Protein Interactions
  • Cancer Research

Background:

  • BAG-1 is a multifunctional protein vital for cellular processes.
  • BAG-1's interaction with heat shock cognate 70 kDa protein (HSC70) is critical.
  • Structural data indicates BAG-1's C-terminal alpha-helices 2 and 3 bind chaperones.

Purpose of the Study:

  • To investigate the role of BAG-1's alpha-helices in HSC70 binding.
  • To determine if specific BAG-1 peptide fragments can disrupt this interaction.
  • To assess the anti-proliferative effects of these peptides on cancer cells.

Main Methods:

  • Peptide synthesis derived from BAG-1 helices 2 and 3.
  • In vitro binding assays to test BAG-1:HSC70 interaction disruption.
  • Cell culture experiments using MCF-7 and ZR-75-1 cancer cell lines.
  • Assessment of cell growth inhibition upon peptide introduction.

Main Results:

  • Peptides from BAG-1 helices 2 and 3 successfully interfered with BAG-1:HSC70 binding.
  • A 12-amino acid peptide from helix 2 directly bound to HSC70.
  • Introduction of these peptides inhibited the growth of MCF-7 and ZR-75-1 cells.

Conclusions:

  • A small domain within BAG-1's alpha-helices is critical for HSC70 interaction.
  • This domain-HSC70 interaction is a potential target for cancer therapy.
  • BAG-1 derived peptides demonstrate anti-cancer properties by inhibiting cell proliferation.

More Related Videos

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...